GRPR and neoplasm: With a significantly lower uptake in the pancreas and a comparable tumor uptake compared with the clinically validated [68Ga]Ga-RM2, [68Ga]Ga-LW01158 is a promising radiopharmaceutical for detecting GRPR-expressing lesions with PET, especially for lesions in or adjacent to the pancreas.